NLC India DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
1.07×1.27×0.75×1.03×0.34×
0.87×0.92×1.23×1.06×1.05×
19.7%18.4%19.3%13.2%25.0%
0.28×0.28×0.27×0.24×0.30×
2.58×2.58×2.64×2.84×3.01×
13.2%15.6%12.6%9.8%8.0%
17.5%17.5%14.9%11.7%9.2%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

NLCINDIA₹227.30

NLC India Ltd.

· Energy & Power
₹ CrorePeersNTPCCOALINDIASJVNNTPCGREENTORNTPOWERVEDPOWERCLEANMAXJSWENERGYMcap ₹31,518 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.341.030.751.271.07
Interest Burden (Pretax/EBIT) ×1.051.061.230.920.87
EBIT Margin %25.0013.1619.3418.3519.69
Asset Turnover ×0.300.240.270.280.28
Financial Leverage (Assets/Equity) ×3.012.842.642.582.58
ROE (5-step product, year-end total equity) %7.979.7812.6415.5713.23
ROE (owners' profit / average owners' equity) %9.2011.7014.8717.5017.50
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.